Farallon Capital builds over 3% stake in Japan's Astellas, FT reports

Astellas Pharma

12/02/2025 05:08

Feb 12 (Reuters) - Farallon Capital Management has built
a stake of more than 3% in Japanese pharmaceutical company
Astellas  4503.T , the Financial Times reported on Wednesday,
citing people familiar with the matter.

 (Reporting by Nilutpal Timsina in Bengaluru; Editing by Savio
D'Souza)
 ((Nilutpal.Timsina@thomsonreuters.com; +91 86382 04706;))